Description
PHARMACEUTICALS - ATOVASTATIN CALCIUM
First action · last action
2014-03-19 · 2014-03-19
Transactions
1
First transaction's obligation
$814,006
Base + all options value (sum of deltas)
$814,006
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
3
SDVOSB flag on record
No
Parent IDV
V797P5156B
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2014-03-19+$814,006= $814,006
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2014-03-19 | +$814,006 | $814,006 | PHARMACEUTICALS - ATOVASTATIN CALCIUM |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI GQLDJJ8AQNN5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36E79726D0041 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36E79726D0042 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36E79726D0022 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36E79726D0014 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36E79726D0023 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36E79726D0018 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under 6505 from 255-NETWORK CONTRACT OFFICE 15 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25516F2420 | CSL BEHRING L.L.C. | 255-NETWORK CONTRACT OFFICE 15 | $5,811 | FY2016 |
| VA25516F2412 | BAYER HEALTHCARE PHARMACEUTICALS INC | 255-NETWORK CONTRACT OFFICE 15 | $51,581 | FY2016 |
| VA25516P2404 | MCKESSON PLASMA AND BIOLOGICS LLC | 255-NETWORK CONTRACT OFFICE 15 | $10,851 | FY2016 |
| VA25516J2221 | RED RIVER PHARMACY OF JONESBORO, LLC | 255-NETWORK CONTRACT OFFICE 15 | $187,797 | FY2016 |
| VA25516D0093 | RED RIVER PHARMACY OF JONESBORO, LLC | 255-NETWORK CONTRACT OFFICE 15 | $0 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25514F2603_3600_V797P5156B_3600 · retrieved 2026-09-26.